The construction of the Orient Ocean Precision Medicine Technology Park project is undoubtedly another milestone move for Orient Ocean to enter the big health industry. The project has a total investment of 1.9 billion yuan and a construction area of 240,000 square meters. It has four major industries: an in vitro diagnostic medical device company, a genetic precision diagnosis company, a mass spectrometry company, and a third-party testing laboratory. Taking this position as a position, Dongfang Ocean's transfer pace is sonorous.
Transferring, Oriental Ocean has already had a successful experience.
In January last year, Oriental Ocean acquired 100% of the shares of Aveco in the United States for 450 million yuan, which caused quite a stir in the industry.
What is the origin of Avico? The company's research and development products are in the world's leading position in the fields of biology, diagnosis, antigen and antibody. It has developed the world's first HIV antigen detection reagent and the world's first FDA-approved HIV diagnostic reagent, and participated in the world's first The R&D and production of a batch of hepatitis B virus diagnostic reagents has applied for more than ten US and global patents, and has provided R&D services for the world's top 500 companies such as Johnson & Johnson and Bidi Medical Devices.
The acquisition of Aveco marks the official entry of Oriental Ocean into the field of the big health industry. In this regard, Che Shi, chairman of Oriental Ocean Technology Co., Ltd., believes that entering the big health has opened the prelude to the development of Oriental Ocean's two-wheel drive.
Oriental Ocean's "record" in aquaculture should not be underestimated
From the original Yantai Aquatic Products Technology Promotion Center to the current technology group with total assets of 3.77 billion, innovation has always been a distinctive sign of Oriental Ocean's leapfrog development. "It can be said that there would be no Oriental Ocean without innovation, which is why we have been focusing on innovation." said Che Shi, Chairman of Oriental Ocean Technology Co., Ltd.
The numbers prove that in the past three years, the R&D investment of Oriental Ocean has been more than 30 million yuan, and the accumulated R&D investment in the past five years is about 200 million yuan. At present, the company has 7 national innovation platforms, 5 provincial innovation platforms, and industry-university-research cooperation. 5 innovation platforms.
The innovative "readers" written by Oriental Ocean are far more than that. Completed genome sequencing and mapping of kelp organisms. This innovation is at the forefront of the world and holds the lifeblood of marine biotechnology; the successful research and development of small molecule collagen peptides has promoted the transformation of marine economic development from extensive growth to intensive efficiency; The local salmon farming technology was successfully developed, and the Chinese people ate their own farmed salmon, breaking the foreign monopoly.
Focusing on the future, Oriental Ocean will focus on developing two sectors, one is the marine aquaculture industry and the other is the precision medical industry. Oriental Ocean people are pursuing excellence with more vigorous fighting spirit and writing a new chapter!